Home › Cytopenia › Pennsylvania
Cytopenia clinical trials in Pennsylvania
3 studies for Cytopenia are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318A Study of Emapalumab for Pediatric Aplastic Anemia
- Children's Hospital of Philadelphia (Data Collection AND Specimen Analysis), Philadelphia
RecruitingPhase 2Healthy volunteers welcome
Ages 0 to 25 · All sexes · Updated Dec 17, 2025 · NCT06430788From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.